These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25793905)

  • 1. Well-defined and reliable clinical outcome assessments for pediatric Crohn disease: a critical need for drug development.
    Sun H; Papadopoulos EJ; Hyams JS; Griebel D; Lee JJ; Tomaino J; Mulberg AE
    J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):729-36. PubMed ID: 25793905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Crohn Disease Clinical Outcome Assessments and Biomarkers: Current State and Path Forward for Global Collaboration.
    Sun H; Vesely R; Lee KJ; Klein A; Ikima M; Mulberg AE;
    J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):368-372. PubMed ID: 27253661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease?
    Turner D; Levine A; Walters TD; Focht G; Otley A; López VN; Koletzko S; Baldassano R; Mack D; Hyams J; Griffiths AM
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):254-260. PubMed ID: 27050050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a pediatric Crohn's disease activity index.
    Hyams JS; Ferry GD; Mandel FS; Gryboski JD; Kibort PM; Kirschner BS; Griffiths AM; Katz AJ; Grand RJ; Boyle JT
    J Pediatr Gastroenterol Nutr; 1991 May; 12(4):439-47. PubMed ID: 1678008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn's disease activity.
    Bennebroek Evertsz' F; Hoeks CC; Nieuwkerk PT; Stokkers PC; Ponsioen CY; Bockting CL; Sanderman R; Sprangers MA
    J Clin Gastroenterol; 2013; 47(10):850-6. PubMed ID: 23632348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions.
    Turner D; Griffiths AM; Walters TD; Seah T; Markowitz J; Pfefferkorn M; Keljo D; Waxman J; Otley A; LeLeiko NS; Mack D; Hyams J; Levine A
    Inflamm Bowel Dis; 2012 Jan; 18(1):55-62. PubMed ID: 21351206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn's disease.
    Kierkus J; Dadalski M; Szymanska E; Oracz G; Wegner A; Gorczewska M; Szymanska S; Woynarowski M; Ryzko J
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):495-500. PubMed ID: 22387887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing activity of pediatric Crohn's disease: which index to use?
    Otley A; Loonen H; Parekh N; Corey M; Sherman PM; Griffiths AM
    Gastroenterology; 1999 Mar; 116(3):527-31. PubMed ID: 10029610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
    Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternate endpoints and clinical outcome assessments in pediatric ulcerative colitis registration trials.
    Sun H; Lee JJ; Papadopoulos EJ; Lee CS; Nelson RM; Sachs HC; Rodriguez WJ; Mulberg AE
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):12-7. PubMed ID: 24121142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease.
    Baldassano R; Braegger CP; Escher JC; DeWoody K; Hendricks DF; Keenan GF; Winter HS
    Am J Gastroenterol; 2003 Apr; 98(4):833-8. PubMed ID: 12738464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Crohn Disease Activity Index: responsive to short-term change.
    Kundhal PS; Critch JN; Zachos M; Otley AR; Stephens D; Griffiths AM
    J Pediatr Gastroenterol Nutr; 2003 Jan; 36(1):83-9. PubMed ID: 12500001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn's Disease: Before and After Induction Therapy.
    Yu Y; Zhao H; Luo Y; Lou J; Chen J; Fang Y
    Dig Dis Sci; 2022 Mar; 67(3):997-1006. PubMed ID: 33818661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations of plasma citrulline levels with clinical and endoscopic score and blood markers according to small bowel involvement in pediatric Crohn disease.
    Lee EH; Ko JS; Seo JK
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):570-5. PubMed ID: 23752073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the Crohn's disease activity index from the Harvey-Bradshaw Index.
    Best WR
    Inflamm Bowel Dis; 2006 Apr; 12(4):304-10. PubMed ID: 16633052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity.
    Khanna R; Zou G; D'Haens G; Feagan BG; Sandborn WJ; Vandervoort MK; Rolleri RL; Bortey E; Paterson C; Forbes WP; Levesque BG
    Aliment Pharmacol Ther; 2015 Jan; 41(1):77-86. PubMed ID: 25348809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties.
    Turner D; Griffiths AM; Walters TD; Seah T; Markowitz J; Pfefferkorn M; Keljo D; Otley A; Leleiko NS; Mack D; Hyams J; Levine A
    Am J Gastroenterol; 2010 Sep; 105(9):2085-92. PubMed ID: 20372111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.